Redeye: Cantargia Q4 2024 - Focus on Business Development
Redeye is only making rather small changes to forecasts and valuation following the full year report, which was largely in line with our forecasts. Absolent has decentralized its organization for more customer focus and direct sales resources. Together with several new product launches in 2025, we see good prospects for higher growth in the years ahead.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/